Copeptin in COVID-19
NCT05249751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2022-02-22
Summary
This study aimed to investigate the change in serum level of copeptin, a neuroendocrine biomarker, in differentiation between mild-moderate and severe COVID-19 cases on admission time and to find its diagnostic potential.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Assessement of serum copeptin by ELISA technique
Assessement of serum copeptin by ELISA technique
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-20
- Primary Completion
- 2021-08-31
- Completion
- 2021-09-10
Countries
- Egypt
Study Locations
More Related Trials
-
Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer.
NCT06080750 ·Status: RECRUITING
-
Hematological Disorders Associated With COVID-19 Infection
NCT05677750 ·Status: COMPLETED
-
Antibodies Responses to COVID-19 Infection in Hospitalized Patients
NCT04520880 ·Status: UNKNOWN
-
A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.
NCT06862531 ·Status: COMPLETED ·Phase: NA
-
Neutralizing Antibody Level After COVID-19 Vaccination
NCT05083026 ·Status: RECRUITING
-
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
NCT04483908 ·Status: COMPLETED
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN
-
Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta
NCT04945811 ·Status: COMPLETED ·Phase: NA
-
Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project
NCT04907890 ·Status: WITHDRAWN
-
Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19
NCT04469153 ·Status: UNKNOWN
-
How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?
NCT05650944 ·Status: COMPLETED
-
PAI-1 Levels and Predicting Covid-19 Patients' Prognosis
NCT04997928 ·Status: UNKNOWN
-
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
NCT04446338 ·Status: UNKNOWN
-
Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
NCT04579471 ·Status: RECRUITING
-
International Study of Inflammation in COVID-19
NCT04818866 ·Status: COMPLETED
-
Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2
NCT04655521 ·Status: COMPLETED
-
Autoimmunity Contributes to the Severe Progression of COVID-19
NCT04967781 ·Status: COMPLETED
-
Profiling the Inflammatory Cascade of COVID-19
NCT06511024 ·Status: COMPLETED
-
Geriatric COVID-19 Serology
NCT05109546 ·Status: UNKNOWN
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19
NCT06676709 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
COVID-19 Antibody and Reinfection Study
NCT05365750 ·Status: COMPLETED
-
Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population
NCT04568850 ·Status: UNKNOWN